Story Navigation
-
DiscoveryCancerDrug DevelopmentOncologyReimagine MedicineTreatments for blood cancers and serious blood disorders are advancing rapidly – Novartis is helping lead the way
Novartis has been at the forefront of advances in how blood cancers and serious blood disorders are treated, helping patients live their best lives.
Discovery -
Live MagazineFuture of HealthcareInnovationMedical InnovationsReimagine MedicineScientific DiscoveriesThe future of medicine is here
An essay by Vas Narasimhan, CEO of Novartis about the historical context and coming innovations in medicine with an introduction by Goran Mijuk.
Live Magazine -
Patient PerspectivesDisease AwarenessDiseasesLiving With DiseasePatient EducationRare DiseasesQ&A: Addressing unmet needs for people living with PNH, a rare and chronic blood disorder
Hear from Director of Patient Services at AAMDSIF on how she supports patients with PNH, a blood disorder that significantly impacts quality of life.
Patient Perspectives -
Patient PerspectivesCancerDisease AwarenessLiving With DiseaseOncologyWhen you think of the word ‘cancer’, what are the first words that spring to mind?
Fighter. Hero. Cancer-stricken. The words and metaphors people use to talk about cancer often feel worlds apart from any other disease. But how far does it go? Do words matter?
Patient Perspectives -
Access to HealthcareAccess to HealthcareClinical ResearchEthical BusinessMedicine SafetyCompassionate use: Providing access to much needed treatments
What happens when a patient’s only treatment hope rests with a promising but not yet locally approved therapy? At Novartis, we are providing a lifeline of access to innovative medicines under review or not yet approved locally when no other treatment options are available.
Access to Healthcare -
Patient PerspectivesProstate cancer and support of the care partner – Carl and Arlene’s story
When Carl was diagnosed with metastatic prostate cancer, he and his wife Arlene began navigating his cancer journey while still looking to enjoy their retirement – hoping to remain active with family and friends in their retirement community.
Patient Perspectives -
People and CultureBiomedical ResearchNovartis Institutes for BioMedical ResearchScientific ResearchDrug DevelopmentWomen in ScienceA scientist from the start – Q&A with NIBR President Fiona MarshallPeople and Culture
-
People and CultureDrug DiscoveryNeurodegenerative DiseaseNeuroscienceNovartis Institutes for BioMedical ResearchScientific ResearchIn neuroscience, “an inflection point in knowledge and technology”People and Culture
-
Patient PerspectivesCancerOncologyPatient VoicesLet’s Talk About the C Word: Navigating a cancer diagnosis and the life beyond it with Leanne Pero
Leanne Pero discusses her experiences of life before, during and after breast cancer, and how it inspired her to advocate for herself and others like her.
Patient Perspectives -
Access to HealthcareAccess to HealthcareClinical ResearchDrug DevelopmentInfectious DiseasesTropical DiseasesRenewing our commitment to neglected tropical disease and malaria elimination
Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases.
Access to Healthcare -
Access to HealthcareAccess to HealthcareAfricaChildren's HealthNovartis AccessSickle cell screening urged for newborns in Africa
Sickle cell disease disproportionately affects babies in Africa, but many go undiagnosed due to lack of screening. Newborn screening is needed to save lives and improve care.
Access to Healthcare -
DiscoveryCancerDrug DiscoveryNovartis Institutes for BioMedical ResearchOncologyWomen in ScienceA shared mission to take on the “impossible” in cancer researchDiscovery